BTWM
BSX icon

Baker Tilly Wealth Management’s Boston Scientific BSX Stock Holding History

Baker Tilly Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,389
Closed -$228K – 287
2025
Q4 		$228K Sell
2,389
-156
-6% -$15.3K 0.06% 257
2025
Q3 		$248K Buy
+2,545
New +$264K 0.06% 241

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Baker Tilly Wealth Management's BSX Position: Q1 2026 in Review

Baker Tilly Wealth Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,389 shares — an estimated $228K sold.

Baker Tilly Wealth Management first reported a position in BSX in Q3 2025 and held it in 2 quarters. The position peaked at $248K in Q3 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Baker Tilly Wealth Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Baker Tilly Wealth Management sold 2,389 Boston Scientific shares in Q1 2026, an estimated $228K.
  • Baker Tilly Wealth Management first reported a position in Boston Scientific in Q3 2025 and held it in 2 quarters.
  • Baker Tilly Wealth Management's Boston Scientific position peaked at $248K in Q3 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.